PipelineReview.com5 天
CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination ...
SUZHOU, China I March 5, 2025 I CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer ...